The following monoclonal antibody is used in senile dementia: (A) Abciximab, (B) Ceolizumab, (C) Bapineuzumab, (D) Vedolizumab
Answer is C. The picture shows monoclonal antibody against beta-amyloid- bapineuzumab -new drug for alzhemier'sdisease.''neu'' in bapineuzumab indicates neuroprotectiveRef:HL and KK Sharma 3rd ed pg 548